✦ LIBER ✦

Sclerodermatous Chronic Gvhd in Patients Receiving Tyrosine Kinase Inhibitors after Allogeneic Hematopoeitic Stem Cell Transplant

✍ Scribed by Salhotra, Amandeep; Palmer, Joycelynne; Tsai, Ni-Chun; Paris, Tanya; Parker, Pablo M.; Forman, Stephen J.; Nakamura, Ryotaro

Book ID: 122153352
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 55 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.12.471

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mediastinal emphysema and bilateral pneu

Mediastinal emphysema and bilateral pneumothoraces with chronic GVHD in patients after allogeneic stem cell transplantation

✍ Toubai, T; Tanaka, J; Kobayashi, N; Honda, T; Miura, Y; Ogawa, T; Imai, K; Ogasa 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

The Decision to Offer Allogeneic Stem Ce

The Decision to Offer Allogeneic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era

✍ Goldman, John M. 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 66 KB

Hepatitis B Virus Reactivation in a Pati

Hepatitis B Virus Reactivation in a Patient With Chronic GVHD After Allogeneic Peripheral Blood Stem Cell Transplantation

✍ Hisashi Sakamaki; Yoriko Sato; Shin-ichiro Mori; Kazuteru Ohashi; Shu Tanikawa; 📂 Article 📅 2001 🏛 Carden Jennings Publishing 🌐 English ⚖ 104 KB

Novel tyrosine kinase inhibitor therapy

Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia : No evidence for increased transplant-related toxicity

✍ Elias Jabbour; Jorge Cortes; Hagop Kantarjian; Sergio Giralt; Borje S. Andersson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## Abstract ## BACKGROUND. Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) for chronic myeloid leukemia (CML) are increasingly likely to have received a novel tyrosine kinase inhibitor (NTKI) after failing imatinib mesylate. It is unknown whether the use of these NTKI

Response to Tyrosine Kinase Inhibitor Th

Response to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia Relapsing in Chronic and Advanced Phase Following Allogeneic Hematopoietic Stem Cell Transplantation

✍ Matthew P. Wright; John D. Shepherd; Michael J. Barnett; Stephen H. Nantel; Heat 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 201 KB

High Incidence of Hyperacute GVHD (HaGVH

High Incidence of Hyperacute GVHD (HaGVHD) in Patients (pts) Undergoing Unrelated Donor Allogeneic Hematopoeitic Stem Cell Transplantation (URalloHSCT) Receiving a Non-Methotrexate (Non-MTX) Containing Regimen

✍ S. Nathan; A.M. Jimenez; J. Maciejewski; E.S. Rich; M. Lo; K. Schultz; H. Fung 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB